Predictors of early response to infliximab in patients with ulcerative colitis
Predictors of early response to infliximab in patients with ulcerative colitis
About this item
Full title
Author / Creator
Publisher
Oxford, UK: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Our objective is to report the outcome of infliximab (IFX) in ulcerative colitis (UC) patients from a single center and to identify predictors of early clinical response.MethodsThe first 100 UC patients (45 female; median age, 37.9 years) who received IFX at a single center were included. Eighty-four patients received 5 mg/kg IFX, and 37 patients r...
Alternative Titles
Full title
Predictors of early response to infliximab in patients with ulcerative colitis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_902333808
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_902333808
Other Identifiers
ISSN
1078-0998
E-ISSN
1536-4844
DOI
10.1002/ibd.20054
